The officer, who was awarded the D.A.R.E. title in 2022, also called alcohol a gateway drug. The post D.A.R.E. Officer of the Year Discusses Relative Using Medical Cannabis for Cancer appeared first on High Times.
A group of doctors advocating for drug policy reform is calling for the regulation of hemp-derived intoxicating cannabinoids. The post Doctors Join Call To Regulate Intoxicating Hemp Cannabinoids appeared first on High Times.
Researchers analyzed self-assessments of nearly eight million people to determine how it has affected medical patients across the country. The post Study: U.S. Medical Cannabis Laws Increase Patient’s Mental Health appeared first on High Times.
Researchers studied legal and illegal cannabis vape products and found exorbitant levels of lead in the illegal samples. The post New Study on Metals in Weed Vapes Presented by Researchers appeared first on High Times.
Under Amazon’s current regulations, CBD product sales are not technically allowed, though that doesn’t stop suppliers from selling them anyway. A new analysis shows that more often than not, consumers aren’t getting what they pay for. The post False Dosage Labels on 96% of Tested Amazon Hemp Products, Many With No Hemp or CBD appeared first on High Times.
Cannabis consumers' organs are often ineligible for transplant, but new evidence states that there’s no significant risk for transplant patients. The post Organs from Cannabis Consumers Don’t Pose Risks of Infection appeared first on High Times.
The powerful anticancer drug interleukin-12 was delivered more safely to lungs via inhalation in mouse models. The post Inhalable Lung Cancer Drug Delivery Performs Well, Study Suggests appeared first on High Times.
Medical cannabis patients in Washington are in line for some much-needed financial relief with the state now set to eliminate an onerous excise tax. The post Washington To Do Away With 37% Medical Cannabis Tax appeared first on High Times.
A new survey sheds light on the efficacy of cannabis medicines for Australian patients with endometriosis alongside the many cost-related barriers associated with access. The post Australian Endometriosis Patients Find Relief Through MMJ Despite Cost Barriers appeared first on High Times.
New research published last month shows that, overall, cannabis users had lower rates of cognitive decline than non-users. The post Study Finds Cannabis Users Have Lower Chance of Cognitive Decline appeared first on High Times.
"While expediting timelines may seem advantageous, the potential negatives embedded within the bill outweigh any perceived benefits. Patient access and rights must take precedence over expediency.” The post Kentucky: Governor Signs Legislation Expediting Medical Cannabis Licensing, But Also Adding New Restrictions Upon Patients’ Access appeared first on NORML.
"These findings belie that claim that cannabis is a so-called 'gateway drug' and reinforces the notion that, for many individuals and for patients especially, it acts as a exit drug." The post Analysis: Medical Cannabis Associated With Decreased Use Of Opioids, Alcohol, And Tobacco appeared first on NORML.
The legislation provides discretion to physicians to issue medical cannabis recommendations to any patient who may benefit from it. It also allows those ages 65 or older to self-certify for a registration card absent a doctor’s recommendation. The post Delaware: Lawmakers Advance Medical Cannabis Expansion Bill to Governor’s Desk appeared first on NORML.
South Dakota voters overwhelmingly approved a ballot measure legalizing medical cannabis access in 2020. Since then, lawmakers have routinely sought to repeal aspects of the law and/or significantly amend it. The post South Dakota: Lawmakers Reject Bill That Sought To Limit Patients’ Medical Cannabis Access appeared first on NORML.
"Individuals reported improvements in overall PTSD symptom severity 30 and 70 days after initiating MMJ [medical marijuana] ... Moreover, they reported reductions in negative affect and improvements in overall well-being. These findings suggest that MMJ use may be associated with clinical benefits in people with PTSD.” The post Study: Cannabis Use Associated With Improved Symptoms, Better Sleep in Patients Suffering From Post-Traumatic Stress appeared first on NORML.
The post Let Veterans Health Administration Doctors Recommend Medical Cannabis appeared first on NORML.
“Our study provides novel information on workers’ use of cannabis for their work-related conditions, a population for which little data exist. … Findings of this study demonstrate workers are turning to cannabis many months following the onset of their original work-related condition." The post Analysis: One in Seven Use Cannabis to Recover from Work-Related Injuries appeared first on NORML.
Multiple improvements to the state’s medical program became law July 1, 2023. The post Virginia: Changes to Medical Cannabis Laws Take Effect appeared first on NORML.
The new law significantly increases the amount of cannabis patients may home cultivate and doubles the amount of THC available in certain marijuana products. The post Vermont: Legislation Becomes Law Increasing THC Limits, Plant Counts for Patients appeared first on NORML.
"This study found no evidence for increased cannabis use among youth living in zip codes with active medical cannabis dispensaries. In fact, 12th graders living in zip codes with dispensaries had lower past-year and past-30-day cannabis use." The post Analysis: Proximity to Cannabis Dispensaries Not Correlated with Higher Rates of Youth Marijuana Use appeared first on NORML.
SAN DIEGO–(BUSINESS WIRE)–Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company The post Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company appeared first on Medical Marijuana, Inc..
World’s First-Ever Publicly Traded Cannabis Company Appoints Longtime Board Member as New CEO SAN DIEGO, CA – March 14, 2023 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), a holding company with operating assets dedicated to the cannabis and hemp industries, along with portfolio investments in companies in the biotechnology industry, announced today the appointment The post Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion appeared first on Medical Marijuana, Inc..
New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant Cost Savings to Rapidly Growing Brazil Market SAN DIEGO, CA – January 24 2023 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical The post Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point appeared first on Medical Marijuana, Inc..
Direct Selling Subsidiary Taps Network Marketing Legends to Lead Communication and Information Technologies as Company Continues International Expansion San Diego, CA – (NewMediaWire ) – November 29, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply The post Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Nov. 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil has been featured across several major press outlets in Brazil including an interview The post Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Oct. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Mexico collaborated with experts from the Meritorious Autonomous University of Puebla, Mexico, The post Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Oct. 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that it has entered into an Asset Purchase Agreement with MFINITY Global LLC, a direct-selling organization The post Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President appeared first on Medical Marijuana, Inc..
Global Cannabis Company Expands Supply Chain in Europe through Agreement with Complete Hemp Technologies SAN DIEGO, CA, Sept. 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its The post Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Aug. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced its financial results for the quarter ending June 30, 2022, and provided an overview of recent The post Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results appeared first on Medical Marijuana, Inc..
SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its pharmaceutical subsidiary, HM Pharma, has submitted a product dossier for its cannabidiol (CBD) products after receiving The post Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil appeared first on Medical Marijuana, Inc..
GreenStar patients receive more than a physician recommendation, we guarantee patients will be educated by a highly credible staff. Our board certified marijuana physician focuses on pain management and cannabis card evaluations for patients throughout Florida, specifically Orange and Seminole Counties (Orlando, Lake Mary, Sanford, Oviedo, Winter Springs, Longwood, Casselberry, and Altamonte Springs). Located less than 1 mile off the Lake Mary I-4 exit.